title: Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.
authors.forename: B
authors.initials: B
authors.lastname: Crestani
authors.forename: J
authors.initials: J
authors.lastname: Chapron
authors.forename: B
authors.initials: B
authors.lastname: Wallaert
authors.forename: E
authors.initials: E
authors.lastname: Bergot
authors.forename: P
authors.initials: P
authors.lastname: Delaval
authors.forename: D
authors.initials: D
authors.lastname: Israel-Biet
authors.forename: J
authors.initials: J
authors.lastname: Lacronique
authors.forename: I
authors.initials: I
authors.lastname: Monnet
authors.forename: M
authors.initials: M
authors.lastname: Reynaud-Gaubert
authors.forename: A
authors.initials: A
authors.lastname: Tazi
authors.forename: R
authors.initials: R
authors.lastname: Lebtahi
authors.forename: M-P
authors.initials: MP
authors.lastname: Debray
authors.forename: M
authors.initials: M
authors.lastname: Brauner
authors.forename: M
authors.initials: M
authors.lastname: Dehoux
authors.forename: Q
authors.initials: Q
authors.lastname: Dornic
authors.forename: M
authors.initials: M
authors.lastname: Aubier
authors.forename: F
authors.initials: F
authors.lastname: Mentré
authors.forename: X
authors.initials: X
authors.lastname: Duval
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D005260:Female; D005602:France; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D012720:Severity of Illness Index; D017211:Treatment Failure
chemical_list: D015415:Biomarkers; D005765:Gastrointestinal Agents; D015282:Octreotide